Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Intra-abdominal recurrence from colorectal carcinoma: Differences and similarities between local and peritoneal recurrence.

Dumont F, Joseph S, Lorimier G, De Franco V, Wernert R, Verriele V, Kerdraon O, Campion L, Capitain O, Guerin-Meyer V, Raimbourg J, Senellart H, Hiret S, Raoul JL, Thibaudeau E.

Surg Oncol. 2019 Nov 4;32:23-29. doi: 10.1016/j.suronc.2019.10.018. [Epub ahead of print]

PMID:
31707314
2.

Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors.

Vogrig A, Fouret M, Joubert B, Picard G, Rogemond V, Pinto AL, Muñiz-Castrillo S, Roger M, Raimbourg J, Dayen C, Grignou L, Pallix-Guyot M, Lannoy J, Ducray F, Desestret V, Psimaras D, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2019 Aug 7;6(6). pii: e604. doi: 10.1212/NXI.0000000000000604. Print 2019 Nov.

3.

Fatal Anti-Ma2 Encephalitis Related to Treatment of Malignant Pleural Mesothelioma With a Combination of Anti-Programmed Death 1 and Anti-Cytotoxic T-Lymphocyte Associated Protein 4 Antibodies.

Du Rusquec P, Peyre A, Toulgoat F, Honnorat J, Raimbourg J.

J Thorac Oncol. 2019 Aug;14(8):e174-e176. doi: 10.1016/j.jtho.2019.03.017. No abstract available.

PMID:
31345342
4.

Significance of lymph node involvement in local recurrence of colorectal cancer.

Dumont F, Muñoz MA, De Franco V, Wernert R, Verriele V, Heyman MF, Kerdraon O, Capitain O, Guerin-Meyer V, Raimbourg J, Senellart H, Hiret S, Raoul JL, Thibaudeau E.

J Surg Oncol. 2019 Sep;120(4):722-728. doi: 10.1002/jso.25631. Epub 2019 Jul 22.

PMID:
31332806
5.

Current options and future possibilities for the systemic treatment of hepatocellular carcinoma.

Raoul JL, Frenel JS, Raimbourg J, Gilabert M.

Hepat Oncol. 2019 Jun 4;6(1):HEP11. doi: 10.2217/hep-2019-0001. Review.

6.

BRAF Non-V600E Mutated Metastatic Colorectal Cancer in a Young Patient: Discussion from a Case Report.

Moisset L, Raimbourg J, Hiret S, Dauve J, Boisdron-Celle M, Senellart H, Raoul JL.

Case Rep Oncol. 2019 Jun 5;12(2):426-429. doi: 10.1159/000500857. eCollection 2019 May-Aug.

7.

Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial.

Reck M, Schenker M, Lee KH, Provencio M, Nishio M, Lesniewski-Kmak K, Sangha R, Ahmed S, Raimbourg J, Feeney K, Corre R, Franke FA, Richardet E, Penrod JR, Yuan Y, Nathan FE, Bhagavatheeswaran P, DeRosa M, Taylor F, Lawrance R, Brahmer J.

Eur J Cancer. 2019 Jul;116:137-147. doi: 10.1016/j.ejca.2019.05.008. Epub 2019 Jun 11.

8.

First case of cutaneous sarcoidosis within tattoos under durvalumab.

Rousseau PM, Raimbourg J, Robert M, Dansette D, Dréno B, Peuvrel L; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments.

Int J Dermatol. 2019 Sep;58(9):e168-e170. doi: 10.1111/ijd.14484. Epub 2019 Jun 4. No abstract available.

PMID:
31162632
9.

Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study.

Shah MA, Kojima T, Hochhauser D, Enzinger P, Raimbourg J, Hollebecque A, Lordick F, Kim SB, Tajika M, Kim HT, Lockhart AC, Arkenau HT, El-Hajbi F, Gupta M, Pfeiffer P, Liu Q, Lunceford J, Kang SP, Bhagia P, Kato K.

JAMA Oncol. 2019 Apr 1;5(4):546-550. doi: 10.1001/jamaoncol.2018.5441.

PMID:
30570649
10.

Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer).

Bennouna J, Barlesi F, Do P, Dumont P, Cadranel J, Debieuvre D, Hilgers W, Molinier O, Quoix E, Raimbourg J, Langlais A, Morin F, Souquet PJ.

ESMO Open. 2018 Jul 23;3(5):e000394. doi: 10.1136/esmoopen-2018-000394. eCollection 2018.

11.

Model predicting the ypN0 status after good response to chemoradiotherapy in rectal cancer.

Dumont F, Dartigues P, Delga B, Thibaudeau E, Benhaim L, Campion L, Mosnier JF, Raimbourg J, Kerdraon O, Goéré D.

Am J Surg. 2018 Sep;216(3):438-443. doi: 10.1016/j.amjsurg.2018.03.025. Epub 2018 Mar 31.

PMID:
29656991
12.

[Hepatocellular carcinoma: Increase in incidence or future plague?]

Raoul JL, Raimbourg J, Hiret S, Adhoute X, Senellart H.

Bull Cancer. 2018 May;105(5):502-507. doi: 10.1016/j.bulcan.2018.02.003. Epub 2018 Mar 19. Review. French.

PMID:
29567280
13.

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.

O'Neil BH, Wallmark JM, Lorente D, Elez E, Raimbourg J, Gomez-Roca C, Ejadi S, Piha-Paul SA, Stein MN, Abdul Razak AR, Dotti K, Santoro A, Cohen RB, Gould M, Saraf S, Stein K, Han SW.

PLoS One. 2017 Dec 28;12(12):e0189848. doi: 10.1371/journal.pone.0189848. eCollection 2017.

14.

Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients.

Delaunay M, Cadranel J, Lusque A, Meyer N, Gounant V, Moro-Sibilot D, Michot JM, Raimbourg J, Girard N, Guisier F, Planchard D, Metivier AC, Tomasini P, Dansin E, Pérol M, Campana M, Gautschi O, Früh M, Fumet JD, Audigier-Valette C, Couraud S, Dalle S, Leccia MT, Jaffro M, Collot S, Prévot G, Milia J, Mazieres J.

Eur Respir J. 2017 Aug 10;50(2). pii: 1700050. doi: 10.1183/13993003.00050-2017. Print 2017 Aug. Erratum in: Eur Respir J. 2017 Nov 9;50(5):.

15.

Sensitization of EGFR Wild-Type Non-Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib.

Raimbourg J, Joalland MP, Cabart M, de Plater L, Bouquet F, Savina A, Decaudin D, Bennouna J, Vallette FM, Lalier L.

Mol Cancer Ther. 2017 Aug;16(8):1634-1644. doi: 10.1158/1535-7163.MCT-17-0075. Epub 2017 May 18.

16.

A comparison of "flat fielding" techniques for x-ray framing cameras.

Benedetti LR, Trosseille C, Holder JP, Piston K, Hargrove D, Bradley DK, Bell P, Raimbourg J, Prat M, Pickworth LA, Khan SF.

Rev Sci Instrum. 2016 Nov;87(11):11D622.

PMID:
27910442
17.

Picosecond X-ray streak camera dynamic range measurement.

Zuber C, Bazzoli S, Brunel P, Fronty JP, Gontier D, Goulmy C, Raimbourg J, Rubbelynck C, Trosseille C.

Rev Sci Instrum. 2016 Sep;87(9):093501.

PMID:
27782554
18.

First set of gated x-ray imaging diagnostics for the Laser Megajoule facility.

Rosch R, Trosseille C, Caillaud T, Allouche V, Bourgade JL, Briat M, Brunel P, Burillo M, Casner A, Depierreux S, Gontier D, Jadaud JP, Le Breton JP, Llavador P, Loupias B, Miquel JL, Oudot G, Perez S, Raimbourg J, Rousseau A, Rousseaux C, Rubbelynck C, Stemmler P, Troussel P, Ulmer JL, Wrobel R, Beauvais P, Pallet M, Prevot V.

Rev Sci Instrum. 2016 Mar;87(3):033706. doi: 10.1063/1.4942930.

PMID:
27036783
19.

Overview of the ARGOS X-ray framing camera for Laser MegaJoule.

Trosseille C, Aubert D, Auger L, Bazzoli S, Beck T, Brunel P, Burillo M, Chollet C, Gazave J, Jasmin S, Maruenda P, Moreau I, Oudot G, Raimbourg J, Soullié G, Stemmler P, Zuber C.

Rev Sci Instrum. 2014 Nov;85(11):11D620. doi: 10.1063/1.4891057.

PMID:
25430196
20.

Hairy-cell leukemia with inaugural joint manifestations.

Raimbourg J, Cormier G, Stéphane Varin, Tanguy G, Bleher Y, Maisonneuve H.

Joint Bone Spine. 2009 Jul;76(4):416-20. doi: 10.1016/j.jbspin.2008.11.011. Epub 2009 Jun 21.

PMID:
19541526
21.

Diagnostics hardening for harsh environment in Laser Megajoule (invited).

Bourgade JL, Marmoret R, Darbon S, Rosch R, Troussel P, Villette B, Glebov V, Shmayda WT, Gomme JC, Le Tonqueze Y, Aubard F, Baggio J, Bazzoli S, Bonneau F, Boutin JY, Caillaud T, Chollet C, Combis P, Disdier L, Gazave J, Girard S, Gontier D, Jaanimagi P, Jacquet HP, Jadaud JP, Landoas O, Legendre J, Leray JL, Maroni R, Meyerhofer DD, Miquel JL, Marshall FJ, Masclet-Gobin I, Pien G, Raimbourg J, Reverdin C, Richard A, Rubin de Cervens D, Sangster CT, Seaux JP, Soullie G, Stoeckl C, Thfoin I, Videau L, Zuber C.

Rev Sci Instrum. 2008 Oct;79(10):10F301. doi: 10.1063/1.2991161.

PMID:
19044614

Supplemental Content

Loading ...
Support Center